The World Pharma pricing and Market Access Congress aims to discuss pricing, patient centricity and global market access. With collaboration high on the agenda, the congress will hear from payers, pharma, patient led organisations and providers.
The congress is now in its 11th year. "It’s about getting the right drug, to the right patient, at the right cost and achieving maximum reimbursement success," according to the congress website.
Amsterdam, The Netherlands
Ask for a Free trial and get access to our last stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.